🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with de novo lipogenesis reduction on glp-1? Page 4

Has anyone dealt with de novo lipogenesis reduction on glp-1?

NurseLeah_Nash Tue, Nov 18, 2025 at 1:33 AM 34 replies 1,698 viewsPage 4 of 7
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Nov 24, 2025 at 2:00 AM#16

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

20 18amsterdam_pete, LondonLisa, mike_nyc and 17 others
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Nov 24, 2025 at 4:46 AM#17
Dr.PeteFamMed said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Genuinely useful, thank you. I had the facts and not the framework.

Last edited: Nov 24, 2025 at 5:46 AM
21 19Dr.AddMedPHL, newstart_MO, mia_MS2 and 18 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Nov 24, 2025 at 7:32 AM#18

From the other side of the consultation, briefly. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

22 20robert_kc, dan_philly, MeganSA_TX and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Nov 24, 2025 at 10:18 AM#19
PharmD_Rodriguez said:
Worth answering the question that was asked rather than the one behind it.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

23 21fiona_VT, denise_HTX, raj_cambridge and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Nov 24, 2025 at 1:04 PM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Report rather than reply if it drifts again.

45 18PurityPaulOR, MaxMetOK, MounjBrad and 42 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register